CG
Column Group Portfolio holdings
AUM
$65.7M
This Quarter Return
-12.38%
1 Year Return
-5.8%
3 Year Return
-15.66%
5 Year Return
–
10 Year Return
–
AUM
$735M
AUM Growth
+$735M
(-16%)
Cap. Flow
-$16.6M
Cap. Flow
% of AUM
-2.25%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
1
Closed
–
Top Buys
| 1 |
Surrozen
SRZN
|
$1.07M |
Top Sells
| 1 |
Oric Pharmaceuticals
ORIC
|
$17.6M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NGM
1
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $273M | 37.08% | 15,396,116 | – | – |
|
2
Tenaya Therapeutics
TNYA
$184M
| $178M | 24.23% | 9,400,290 | – | – |
|
3
Revolution Medicines
RVMD
$7.1B
| $84.3M | 11.46% | 3,347,245 | – | – |
|
|
4
Surrozen
SRZN
$104M
| $60.6M | 8.25% | 9,414,795 +166,666 | +2% | +$1.07M |
|
|
5
Oric Pharmaceuticals
ORIC
$994M
| $52.5M | 7.13% | 3,568,181 -1,200,000 | -25% | -$17.6M |
|
6
RAPT Therapeutics
RAPT
$188M
| $51.5M | 7% | 1,402,008 | – | – |
|
|
EFTR
7
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| $35.7M | 4.85% | 4,309,329 | – | – |
|